Google Custom Search
HIV and AIDS Top News Articles
   
Traditional Risk Factors Predict Cardiovascular Risk in People with HIV
8-31-2010
HIV Positive People Could Benefit from Aspirin to Reduce Cardiovascular Risk
8-31-2010
Opportunistic Infections in the U.S. during the Combination Antiretroviral Therapy Era
8-31-2010
People with CD4 Counts below 200 May Stop Pneumocystis Pneumonia Prophylaxis if Viral Load Is Undetectable
8-31-2010
Swedish Study Confirms Brain Is Reservoir for HIV
8-31-2010
Researchers Identify TRIM5a Protein that Destroys HIV in Monkeys
8-31-2010
Bone Loss Is Common among HIV Positive Men, Linked to AIDS Diagnosis and Heroin Use
8-27-2010
Immune Activation and Exhaustion Occur Together in People with HIV
8-27-2010
Inflammation and Its Relation to Gut Bacteria in People with Chronic HIV Infection
8-27-2010
Promising Long-term Outcomes for Adolescents with Perinatal HIV Infection
8-27-2010
Researchers Identify Novel HIV Entry Inhibitor, May Be Suitable for Microbicide
8-27-2010
Most Chronic Fatigue Syndrome Patients Show Evidence of Murine Leukemia Virus-related Infection
8-27-2010
Test-and-Treat Strategy Would Improve Survival and Reduce HIV Transmission in Washington, DC
8-24-2010
HPV-associated Cancer among HIV Positive Men and Women in the Combination ART Era
8-24-2010
HIV Treatment Advances Have Not Decreased Mortality among Disadvantaged Groups in San Francisco
8-24-2010
Researchers Identify FDA-Approved Drugs Active Against HIV in Mice
8-24-2010
Combination of Integrase Promoter and Protease Inhibitor May Offer Novel Approach to HIV Eradication
8-20-2010
DHHS Pediatric Antiretroviral Treatment Guidelines Updated
8-20-2010
Long-term Non-progression of HIV Disease without Antiretroviral Treatment Is Uncommon
8-20-2010
Switching from Efavirenz to Etravirine Reduces Central Nervous System Side Effects
8-20-2010
Transmission of Drug-resistant HIV Increases Risk of Treatment Failure
8-20-2010
Boosted Darunavir (Prezista) Monotherapy Provides Durable Viral Suppression for Most HIV Patients
8-17-2010
People with HIV Develop Non-AIDS Cancers Earlier and More Often, despite Antiretroviral Therapy
8-17-2010
Maraviroc (Selzentry) Not Associated with Elevated Cancer Risk in Clinical Development Program
8-17-2010
New Analysis Estimates Future Course of U.S. HIV Epidemic
8-17-2010
HIV Infection, Lower CD4 Cell Count Associated with Increased Risk of Cardiovascular Disease
8-17-2010
Abacavir Not Linked to Cardiovascular Events in Meta-analysis or Large French Cohort
8-17-2010
Nutritional Supplements May Slow HIV Disease Progression, Boost Immune Recovery, and Lessen Mitochondrial Toxicity
8-17-2010
Black AIDS Institute and Merck Launch New Black Treatment Advocates Network
8-17-2010
CHARTER Study Finds Neurocognitive Impairment Still Common in ART Era, Linked to Lowest CD4 Cell Count
8-06-2010
"Armoring" Cells by Strengthening Membranes May Inhibit HIV Entry
8-06-2010
Half of Children Born to HIV Positive Mothers Do Not Receive Preventive Antiretroviral Drugs
8-06-2010
Novel Tenofovir Hexadecyloxypropyl Formulation CMX157 Active against NRTI-resistant HIV
8-06-2010
Investigational HIV Drug TBR-652 Reduces Viral Replication and May Dampen Inflammation
8-06-2010
Switching from Boosted Protease Inhibitor to Raltegravir Maintains Viral Suppression in Absence of NRTI Resistance
8-06-2010
Majority of HIV Positive People on Antiretroviral Therapy May Have Reduced Bone Density
8-06-2010
National Osteoporosis Foundation Recommends Bone Density Testing for Women over 65, Men over 70
8-06-2010
Studies Explore NRTI-sparing Antiretroviral Regimens Using New Drug Classes
7-30-2010
Atazanavir (Reyataz) in Combination with Abacavir/Lamivudine (Epzicom) Is a Potent and Well-tolerated Regimen
7-30-2010
Oral Tenofovir for Pre-exposure Prophylaxis Appears Safe and Does Not Discourage Safer Sex
7-30-2010
Early Antiretroviral Therapy during Tuberculosis Treatment Improves Survival
7-30-2010
CASCADE Study Shows Antiretroviral Therapy Is Beneficial above CD4 Cell Count of 350, Less Clear above 500
7-27-2010
Randomized Trial in Haiti Shows Benefits of Early Antiretroviral Therapy
7-27-2010
New NNRTI Rilpivirine (TMC278) Shows Potent Antiviral Activity and Good Tolerability in Phase 3 Trials, FDA Application Submitted
7-27-2010
Once-daily Extended Release Nevirapine (Viramune) Equals Twice-daily Immediate Release Formulation
7-27-2010
Global Experts Call for Better Match between HIV Prevention Efforts and Groups at Greatest Risk
7-27-2010
Experts Promote "Seek, Test, Treat and Retain" Paradigm and Opioid Substitution for Injection Drug Users
7-27-2010
New International AIDS Society-USA Guidelines Recommend Starting Antiretroviral Therapy at 500
7-23-2010
Early Antiretroviral Treatment Reduces New HIV Infections, Says British Columbia Study
7-23-2010
NRTI-sparing Regimen of Lopinavir/ritonavir plus Raltegravir Works as Well as Traditional 3-drug HAART
7-23-2010
More Promising Data on GSK572 Integrase Inhibitor, Phase 3 Studies to Begin Soon
7-23-2010
CDC Study Reveals High HIV Infection Rates Linked to Poverty More Than Race
7-23-2010
IAPAC Survey Finds Gaps in Patient-Physician Conversations Affect Treatment Outcomes
7-23-2010
AIDS 2010 Opens with Focus on Human Rights of People with HIV
7-20-2010
CAPRISA Microbicide Trial Shows Tenofovir Vaginal Gel Reduces HIV Transmission Risk by 39%
7-20-2010
Histone Deacetylase Inhibitor Both Actives Latent CD4 Cells and Reduces Coreceptor Expression
7-20-2010
Cure for HIV Is Feasible and Necessary, Experts Say
7-20-2010
Zinc Finger Stem Cell Gene Therapy Produces HIV-resistant Immune Cells in Mice
7-20-2010
Experts Call for "New Era" of Unified HIV Vaccine Research
7-20-2010
AIDS 2010 -- International AIDS Conference Begins Sunday in Vienna
7-16-2010
White House Releases Long-awaited National AIDS Strategy
7-16-2010
10 Million Deaths and 1 Million New HIV Infections Could Be Averted if Countries Meet HIV Treatment Targets, Says New UNAIDS Report
7-16-2010
Despite Extensive Mutation, Some Original HIV Strains Likely Persist in Long-term Reservoirs
7-16-2010
Switching from a Boosted Protease Inhibitor to Raltegravir (Isentress) Maintains Viral Suppression, but with Better Lipid Profiles
7-16-2010
Merck Decides to Stop Development of Vicriviroc for Treatment of HIV
7-16-2010
ViiV Launches New Initiative to Fund Community HIV/AIDS Programs in Southern U.S.
7-16-2010
Elevated Inflammation Biomarkers Linked to Increased Mortality in People with HIV
7-13-2010
Abacavir Not Associated with Inflammation in 2 Large U.S. HIV Cohorts
7-13-2010
Immune Activation and Inflammation Due to Leaking Gut Bacteria Linked to HIV Disease Progression
7-13-2010
Atripla Payment Assistance Eliminates Initial Out-of-pocket Co-payment
7-13-2010
Scientists at the U.S. National Institutes of Health Discover Human Antibodies That Can Stop Most HIV Strains from Infecting Human Cells
7-09-2010
Late Antiretroviral Therapy Raises Risk of Early Atherosclerosis
7-09-2010
Pentoxifylline May Improve Endothelial Dysfunction in People with HIV
7-09-2010
Biomarkers of Inflammation and Cardiovascular Risk in HIV Positive Children
7-09-2010
Toll-Like Receptor 9 Genetic Variation Increases Risk of Mother-to-Child HIV Transmission
7-09-2010
Viral Load Increase and CD4 Cell Loss Closely Linked in Untreated People with HIV
7-06-2010
United Nations Development Programme Launches Global Commission on HIV and the Law
7-06-2010
Vienna Declaration Calls for Health-focused Drug Policy, International AIDS Conference Deadline July 13
7-02-2010
Revised Raltegravir (Isentress) Label Adds 96 Week Data
7-02-2010
Suboptimal Adherence Has Less Effect on Boosted Darunavir (Prezista) than Lopinavir/ritonavir (Kaletra)
7-02-2010
Normally Anti-inflammatory Enzyme Reduces Gut Integrity in People with HIV, Leading to Increased Inflammation
7-02-2010
New NIH Martin Delaney Collaboratory Will Fund HIV/AIDS Cure Research
7-02-2010
June 27 Is National HIV Testing Day
6-25-2010
Slow Viral Load Suppression after Starting Antiretroviral Therapy Does Not Lead to Worse Long-term Outcomes
6-25-2010
Fatigue Is Common in People with HIV and Often Linked to Depression
6-25-2010
Updated World Health Organization Guidelines Recommend Antiretroviral Therapy for All Babies with HIV under Age 2
6-25-2010
International Labour Organization Adopts Workplace Policies for People with HIV/AIDS
6-25-2010
Host and Viral Characteristics Influence the Speed and Severity of HIV Disease Progression
6-22-2010
Stem Cell Gene Therapy Appears Safe, May Protect Cells against HIV Infection
6-22-2010
Nucleic Acid HIV Test Turns Up More Positive Results than Standard Antibody Tests
6-22-2010
FDA Approves Abbott Test that Detects both HIV Antigens and Antibodies
6-22-2010
Get Yourself Tested Campaign Offers Free HIV Tests in 10 Cities; CDC Launches Primary Care HIV Screening Program
6-22-2010
Military Study Shows Universal HIV Care Linked to Better Treatment Response
6-18-2010
Researchers Gain New Insight into Crystal Structure of HIV Tat Protein
6-18-2010
Antiretroviral Therapy for Mother or Infant Reduces HIV Transmission during Breast-feeding
6-18-2010
CDC Releases 2008 Surveillance Report Showing Higher Number of People Living with HIV, but Stable Rate of New Infections
6-18-2010
Latest ADAP Numbers Show More than 1400 People on Waiting Lists in 11 States
6-18-2010
Inflammation Biomarkers are Elevated in People with HIV even after Viral Suppression on Antiretroviral Therapy
6-15-2010
Large Meta-analysis Finds No Link between Efavirenz (Sustiva) and Birth Defects
6-15-2010
DHHS Advisory Committee Keeps Gay Blood Donation Ban
6-15-2010
New amfAR Consortium on HIV Eradication Awards First Grants for AIDS Cure Research
6-15-2010
ViiV Healthcare and Elizabeth Glaser Pediatric AIDS Foundation Announce Partnership to Expand Treatment for Infants and Children with HIV
6-15-2010
Mathematical Model Shows Individual and Public Health Benefits of Earlier Antiretroviral Therapy
6-11-2010
Zinc Supplements Delay CD4 Cell Loss and Reduce Diarrhea in People with HIV
6-11-2010
Myriad Halts Development of HIV Maturation Inhibitor Bevirimat
6-11-2010
International Partnership for Microbicides Begins First Trial of Dapivirine Vaginal Ring for HIV Prevention
6-11-2010
June 8 is Caribbean American HIV/AIDS Awareness Day
6-08-2010
San Francisco and California Officials Honor Doctor Who Cured "Berlin Patient"
6-08-2010
Maraviroc (Selzentry) Label Adds Dosing Recommendations for People with Kidney Impairment
6-08-2010
White House Office of National AIDS Policy Holds First Meeting on Black Men and HIV
6-08-2010
Gilead, ViiV Healthcare Announce Agreements with ADAP Crisis Task Force for Further Drug Discounts
6-08-2010
San Francisco HIV/HCV Coinfection Community Forum on June 7
6-04-2010
FDA Committee Unanimously Votes to Approve Tesamorelin (Egrifta) for Lipodystrophy
6-04-2010
Antiretroviral Therapy Reduces Heterosexual HIV Transmission Risk by More than 90%
6-04-2010
Antiretroviral Therapy for HIV Prevention Could Lead to Drug Resistance If Not Carefully Implemented
6-04-2010
Pressure Grows to Lift Ban on Blood Donation by Gay Men
6-04-2010
Tibotec Launches Web Portal for HIV Case Managers
6-04-2010
Microbicides Conference Discusses Promising New Prevention Approaches, Unexpected Concerns
5-28-2010
U.S. Panel Releases Updated Pregnancy and Perinatal HIV Treatment Guidelines
5-28-2010
Frequent Alcohol Use Linked to Lower CD4 Cell Count and Higher HIV Viral Load
5-28-2010
Researchers Identify Genetic Mutation that Influences Drug Levels in the Body
5-28-2010
Niacin May Improve Blood Vessel Function in People with HIV
5-25-2010
Cholesterol Crystals Trigger Inflammation Leading to Atherosclerosis
5-25-2010
Project Inform Clarifies Position on Early Treatment for HIV
5-25-2010
Less than Half of Drug Addiction Treatment Programs Screen for Infectious Diseases such as HIV and Hepatitis B or C
5-25-2010
Half of North American HIV Patients Access Care Late and Are Eligible for Immediate Antiretroviral Treatment
5-21-2010
Did Halting Smallpox Vaccination Spur the AIDS Epidemic?
5-21-2010
How Well Do Needle Exchange Programs Work?
5-21-2010
San Francisco Senator Leland Yee Introduces Legislation to Allow Pharmacies to Sell Non-prescription Syringes
5-21-2010
May 18 is HIV Vaccine Awareness Day
5-18-2010
May 19 is National Asian and Pacific Islander HIV/AIDS Awareness Day
5-18-2010
Short Cycles of Intermittent Antiretroviral Therapy as Effective as Continuous Treatment in Uganda Study
5-18-2010
Tenofovir-related Kidney Toxicity Linked to High Drug Concentrations, May Not Always Be Reversible
5-18-2010
National AIDS Fund Announces Grants to Community-based Organizations to Improve Access to Care for People with HIV
5-18-2010
Causes of Death among People with HIV Continue to Shift toward non-AIDS Conditions
5-14-2010
Genetic Variation in Elite Controllers Linked to Stronger T-cell Response against HIV
5-14-2010
ADAP Waiting List Exceeds 1000, Drug Companies Agree to Price Freezes and Expanded Patient Assistance
5-14-2010
Drug Resistance and Treatment Failure in Antiretroviral Therapy Era
5-11-2010
CD4 Cell Death May Explain Poor Immunological Recovery on Antiretroviral Therapy
5-11-2010
Antiretroviral Therapy at Conception Reduces Risk of Mother-to-child HIV Transmission
5-11-2010
Avexa Announces End to Development of Experimental NRTI Apricitabine
5-11-2010
Failure of 3 Antiretroviral Classes Is Uncommon, but Causes Some People with HIV to Require New Drugs
5-7-2010
Monoclonal Antibody PRO 140 Suppresses HIV Viral Load with Once-weekly Dosing
5-7-2010
Risk of HIV Transmission Decreases after 12 Months on Successful Antiretroviral Therapy
5-7-2010
Minority NNRTI-resistant HIV Variants Can Lead to Treatment Failure
5-4-2010
Is Drug Resistance More Likely with Lamivudine (Epivir) than with Emtricitabine (Emtriva)?
5-4-2010
Rectal Gonorrhea, Chlamydia, and Syphilis Are Associated with Increased Risk of HIV Infection
5-4-2010
FDA Approves Once-daily Lopinavir/ritonavir (Kaletra) for Certain Treatment-experienced HIV Patients
4-30-2010
FDA Announces New Drug Interaction Label Information for Protease Inhibitors
4-30-2010
Three Studies Look at Cancer Risk among People with HIV
4-30-2010
Etravirine (Intelence) Demonstrates Safety and Efficacy in Traditional HAART and Novel Salvage Regimen
4-27-2010
People with HIV Often Have Elevated Homocysteine Levels during Antiretroviral Treatment
4-27-2010
Many People with HIV Remain Undiagnosed, Rates Vary across Demographic and Risk Groups
4-27-2010
People with HIV Are Still Commonly Hospitalized in the Era of Effective Antiretroviral Therapy
4-23-2010
HIV Increases Permeability of Mucosal Cell Barrier, Facilitating Entry via Female Genital Tract
4-23-2010
Gilead Working on Once-daily Coformulation of Tibotec NNRTI Rilpivirine TMC278) plus Tenofovir/emtricitabine
4-23-2010
International AIDS Society Credits Antiretroviral Therapy with Helping to Lower Maternal Mortality
4-23-2010
Cytokine Biomarker Levels during Acute HIV Infection Predict Disease Progression
4-20-2010
Drug Resistance Testing May Be Useful Even if HIV Viral Load Is Low
4-20-2010
FDA Approves New Oral Drug for Mouth and Throat Candidiasis
4-20-2010
Can Morphine Help Protect the Brain against HIV Neurotoxicity and Cognitive Impairment?
4-20-2010
White House Office of National AIDS Policy Releases Report Compiling Recommendations from Community Meetings
4-20-2010
San Francisco Health Officials Announce New Policy of Universal HIV Treatment Regardless of CD4 Cell Count
4-16-2010
Adherence to Antiretroviral Therapy May Improve over Time
4-16-2010
Gilead Begins First Phase 3 Clinical Trial of Boosted Elvitegravir Quad Pill
4-16-2010
Efavirenz (Sustiva) Label Updated with New Information about Adverse Events and Drug Interactions
4-16-2010
Male Circumcision May Provide Women Some Protection against HIV Infection
4-16-2010
Once-daily Antiretroviral Therapy Regimens Lead to Better Adherence
4-13-2010
CD4 Cell Count Predicts Non-AIDS Disease and Death in People with HIV
4-13-2010
Mother's Use of Antiretroviral Drugs during First Trimester Not Linked to Increased Risk of Birth Defects
4-13-2010
HIV RNA Level of HIV Positive Partner Predicts Viral Load of Newly Infected Individuals
4-13-2010
Anti-HIV Drugs Show Activity against XMRV Retrovirus Linked to Prostate Cancer and Chronic Fatigue Syndrome
4-13-2010
Switching to Atazanavir (Reyataz) Lowers Cholesterol and Triglycerides, but No Improvement in Artery Function
4-6-2010
Risk Factors for Neurocognitive Impairment among People with HIV
4-6-2010
Impaired Sexual Function Is Common among Women with HIV
4-6-2010
CDC to Increase Funding for HIV Testing, Focusing on Disproportionately Affected Groups
4-6-2010
HIV Positive People Are at Increased Risk for MRSA Drug-resistant Staph Infection
4-2-2010
Heavy Alcohol Use Increases Risk of Cardiovascular Disease in Men with HIV
4-2-2010
Growth Hormone Releasing Factor Tesamorelin Reduces Visceral Fat in HIV Positive People with Lipodystrophy
4-2-2010
FDA to Hold Public Meeting on May 27 to Discuss Approval of Tesamorelin (Egrifta)
4-2-2010
First-line Antiretroviral Therapy Is Becoming Simpler and More Consistent
3-30-2010
Studies Look at Antiretroviral Drug Levels in Genital Fluids, Prospects for Use in Microbicides
3-30-2010
Tenofovir (Viread) Approval Expanded to Include HIV Positive Adolescents Ages 12 to 18
3-30-2010
Stories of Success in HIV: Proven Interventions for Improving Awareness, Testing, Access to Care, and Treatment of HIV in Communities of Color.
This issue provides expert commentaries and clinical insights from the Conference on Retroviruses and Opportunistic Infections (CROI) 2010*.
Applying proven interventions for improving awareness, testing, access to care,
and treatment for communities of color.
Reports on Most Recent
HIV-related
Research Conferences
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors EIs
Integrase Inhibitors

Experimental Treatments
HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children